<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35436552</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>24</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>24</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1873-6351</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>164</Volume>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association</Title>
          <ISOAbbreviation>Food Chem Toxicol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs.</ArticleTitle>
        <Pagination>
          <StartPage>113008</StartPage>
          <MedlinePgn>113008</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fct.2022.113008</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0278-6915(22)00206-X</ELocationID>
        <Abstract>
          <AbstractText>The mRNA SARS-CoV-2 vaccines were brought to market in response to the public health crises of Covid-19. The utilization of mRNA vaccines in the context of infectious disease has no precedent. The many alterations in the vaccine mRNA hide the mRNA from cellular defenses and promote a longer biological half-life and high production of spike protein. However, the immune response to the vaccine is very different from that to a SARS-CoV-2 infection. In this paper, we present evidence that vaccination induces a profound impairment in type I interferon signaling, which has diverse adverse consequences to human health. Immune cells that have taken up the vaccine nanoparticles release into circulation large numbers of exosomes containing spike protein along with critical microRNAs that induce a signaling response in recipient cells at distant sites. We also identify potential profound disturbances in regulatory control of protein synthesis and cancer surveillance. These disturbances potentially have a causal link to neurodegenerative disease, myocarditis, immune thrombocytopenia, Bell's palsy, liver disease, impaired adaptive immunity, impaired DNA damage response and tumorigenesis. We show evidence from the VAERS database supporting our hypothesis. We believe a comprehensive risk/benefit assessment of the mRNA vaccines questions them as positive contributors to public health.</AbstractText>
          <CopyrightInformation>Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Seneff</LastName>
            <ForeName>Stephanie</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Computer Science and Artificial Intelligence Laboratory, MIT, Cambridge, MA, USA, 02139. Electronic address: seneff@csail.mit.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nigh</LastName>
            <ForeName>Greg</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Immersion Health, Portland, OR, 97214, USA. Electronic address: drnigh@immersionhealthpdx.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kyriakopoulos</LastName>
            <ForeName>Anthony M</ForeName>
            <Initials>AM</Initials>
            <AffiliationInfo>
              <Affiliation>Research and Development, Nasco AD Biotechnology Laboratory, Department of Research and Development, Sachtouri 11, 18536, Piraeus, Greece. Electronic address: antkyriak@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>McCullough</LastName>
            <ForeName>Peter A</ForeName>
            <Initials>PA</Initials>
            <AffiliationInfo>
              <Affiliation>Truth for Health Foundation, Tucson, AZ, USA. Electronic address: peteramccullough@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>15</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Food Chem Toxicol</MedlineTA>
        <NlmUniqueID>8207483</NlmUniqueID>
        <ISSNLinking>0278-6915</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
          <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055354" MajorTopicYN="Y">Exosomes</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D054856" MajorTopicYN="Y">G-Quadruplexes</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Cancer</Keyword>
        <Keyword MajorTopicYN="N">Exosomes</Keyword>
        <Keyword MajorTopicYN="N">G-quadruplexes</Keyword>
        <Keyword MajorTopicYN="N">SARS-CoV-2 mRNA vaccines</Keyword>
        <Keyword MajorTopicYN="N">Type I interferon Response</Keyword>
        <Keyword MajorTopicYN="N">microRNAs</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>3</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>8</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>18</Day>
          <Hour>20</Hour>
          <Minute>7</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35436552</ArticleId>
        <ArticleId IdType="pmc">PMC9012513</ArticleId>
        <ArticleId IdType="doi">10.1016/j.fct.2022.113008</ArticleId>
        <ArticleId IdType="pii">S0278-6915(22)00206-X</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Abe M., Bonini N.M. MicroRNAs and neurodegeneration: role and impact. Trends Cell Biol. 2013;23(1):30–36. doi: 10.1016/j.tcb.2012.08.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tcb.2012.08.013</ArticleId>
            <ArticleId IdType="pmc">PMC3540990</ArticleId>
            <ArticleId IdType="pubmed">23026030</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Agashe D., Martinez-Gomez N.C., Drummond D.A., Marx C.J. Good codons, bad transcript: large reductions in gene expression and fitness arising from synonymous mutations in a key enzyme. Mol. Biol. Evol. 2013;30:549–560. doi: 10.1093/molbev/mss273.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/molbev/mss273</ArticleId>
            <ArticleId IdType="pmc">PMC3563975</ArticleId>
            <ArticleId IdType="pubmed">23223712</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Akiyama H., Kakiuchi S., Rikitake J., Matsuba H., Sekinada D., Kozuki Y., Iwata N. Immune thrombocytopenia associated with Pfizer-BioNTech’s BNT162b2 mRNA COVID-19 vaccine. IDCases. 2021;25 doi: 10.1016/j.idcr.2021.e01245.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.idcr.2021.e01245</ArticleId>
            <ArticleId IdType="pmc">PMC8336989</ArticleId>
            <ArticleId IdType="pubmed">34381692</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Al-Khalaf H.H., Aboussekhra A. p16 controls p53 protein expression through miR-dependent destabilization of MDM2. Mol. Cancer Res. 2018;16(8):1299–1308. doi: 10.1158/1541-7786.MCR-18-0017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/1541-7786.MCR-18-0017</ArticleId>
            <ArticleId IdType="pubmed">29739873</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alsamman K., El-Masry O.S. Interferon regulatory factor 1 inactivation in human cancer. Biosci. Rep. 2018;38(3) doi: 10.1042/BSR20171672. 2018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1042/BSR20171672</ArticleId>
            <ArticleId IdType="pmc">PMC5938431</ArticleId>
            <ArticleId IdType="pubmed">29599126</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Andries O., Mc Cafferty S., De Smedt S.C., Weiss R., Sanders N.N., Kitada T. N1-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice. J. Contr. Release. 2015;217:337–344. doi: 10.1016/j.jconrel.2015.08.051.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jconrel.2015.08.051</ArticleId>
            <ArticleId IdType="pubmed">26342664</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Asmana Ningrum R. Human interferon α-2b: a therapeutic protein for cancer treatment. Sci. Tech. Rep. 2014 doi: 10.1155/2014/970315. 2014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2014/970315</ArticleId>
            <ArticleId IdType="pmc">PMC3967813</ArticleId>
            <ArticleId IdType="pubmed">24741445</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Atoui A., Jarrah K., Al Mahmasani L., Bou‐Fakhredin R., Taher A.T. Deep venous thrombosis and pulmonary embolism after COVID‐19 mRNA vaccination. Ann. Hematol. 2022:1–3. doi: 10.1007/s00277-021-04743-1. [Epub ahead of print]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00277-021-04743-1</ArticleId>
            <ArticleId IdType="pmc">PMC8791702</ArticleId>
            <ArticleId IdType="pubmed">35083524</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Avolio E., Gamez M., Gupta K., Foster R., Berger I., Caputo M., Davidson A., Hill B., Madeddu P. The SARS-CoV-2 spike protein disrupts the cooperative function of human cardiac pericytes - endothelial cells through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease. bioRxiv preprint. 2020 doi: 10.1101/2020.12.21.423721. December 21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/2020.12.21.423721</ArticleId>
            <ArticleId IdType="pmc">PMC8674568</ArticleId>
            <ArticleId IdType="pubmed">34807265</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Babendure J.R., Babendure J.L., Ding J.H., Tsien R.Y. Control of mammalian translation by mRNA structure near caps. RNA. 2006;12(5):851–861. doi: 10.1261/rna.2309906.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1261/rna.2309906</ArticleId>
            <ArticleId IdType="pmc">PMC1440912</ArticleId>
            <ArticleId IdType="pubmed">16540693</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Babic T., Browning K.N. The role of vagal neurocircuits in the regulation of nausea and vomiting. Eur. J. Pharmacol. 2014;722:38–47. doi: 10.1016/j.ejphar.2013.08.047.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ejphar.2013.08.047</ArticleId>
            <ArticleId IdType="pmc">PMC3893663</ArticleId>
            <ArticleId IdType="pubmed">24184670</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bahl K., Senn J.J., Yuzhakov O., Bulychev A., Brito L.A., Hassett K.J., Laska M.E., Smith M., Almarsson Ö., Thompson J., et al.  Preclinical and clinical demonstration of immunogenicity by mRNA vaccines against H10N8 and H7N9 influenza viruses. Mol. Ther. 2017;25(6):1316–1327. doi: 10.1016/j.ymthe.2017.03.035.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ymthe.2017.03.035</ArticleId>
            <ArticleId IdType="pmc">PMC5475249</ArticleId>
            <ArticleId IdType="pubmed">28457665</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bansal S., Perincheri S., Fleming T., Poulson C., Tiffany B., Bremner R.M., Mohanakumar T. Cutting edge: circulating exosomes with COVID spike protein are induced by BNT162b2 (PfizerBioN-Tech) vaccination prior to development of antibodies: a novel mechanism for immune activation by mRNA vaccines. J. Immunol. 2021;207(10):2405–2410. doi: 10.4049/jimmunol.2100637.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.2100637</ArticleId>
            <ArticleId IdType="pubmed">34654691</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barone V., Camilli F., Crisci M., Scandellari C., Barboni P., Lugaresia A. Inflammatory optic neuropathy following SARS-CoV-2 mRNA vaccine: description of two cases. J. Neurol. Sci. 2021;429:118186. doi: 10.1016/j.jns.2021.118186.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jns.2021.118186</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bezzi G., Piga E.J., Binolfi A., Armas P. CNBP binds and unfolds in vitro G-quadruplexes formed in the SARS-CoV-2 positive and negative genome strands. Int. J. Mol. Sci. 2021;22(5):2614. doi: 10.3390/ijms22052614.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms22052614</ArticleId>
            <ArticleId IdType="pmc">PMC7961906</ArticleId>
            <ArticleId IdType="pubmed">33807682</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bhurani V., Mohankrishnan A., Morrot A., Dalai S.K. Developing effective vaccines: cues from natural infection. Int. Rev. Immunol. 2018;37(5):249–265. doi: 10.1080/08830185.2018.1471479.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/08830185.2018.1471479</ArticleId>
            <ArticleId IdType="pubmed">29927676</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bidwell B.N., Slaney C.Y., Withana N.P., Forster S., Cao Y., Loi S., Andrews D., Mikeska T., Mangan N.E., Samarajiwa S.A., et al.  Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape. Nat. Med. 2012;18(8):1224–1231. doi: 10.1038/nm.2830.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm.2830</ArticleId>
            <ArticleId IdType="pubmed">22820642</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blanco-Melo D., Nilsson-Payant B.E., Liu W.C., Uhl S., Hoagland D., Møller R., Jordan T.X., Oishi K., Panis M., Sachs D., et al.  Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell. 2020;181(5):1036–1045 e9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7227586</ArticleId>
            <ArticleId IdType="pubmed">32416070</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Borbolis F., Syntichaki P. Cytoplasmic mRNA turnover and ageing. Mech. Ageing Dev. 2015;152:32–42. doi: 10.1016/j.mad.2015.09.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.mad.2015.09.006</ArticleId>
            <ArticleId IdType="pmc">PMC4710634</ArticleId>
            <ArticleId IdType="pubmed">26432921</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brosh-Nissimov T., Orenbuch-Harroch E., Chowers M., Elbaz M., Nesher L., Stein M., Maor Y., Cohen R., Hussein K., Weinberger M., et al.  BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel. Clin. Microbiol. Infect. 2021;27(11):1652–1657. doi: 10.1016/j.cmi.2021.06.036.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmi.2021.06.036</ArticleId>
            <ArticleId IdType="pmc">PMC8261136</ArticleId>
            <ArticleId IdType="pubmed">34245907</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Buckley N.E., Hosey A.M., Gorski J.J., Purcell J.W., Mulligan J.M., Harkin D.P., Mullan P.B. BRCA1 regulates IFN-γ signaling through a mechanism involving the type I IFNs. Mol. Cancer Res. 2007;5(3):261–270. doi: 10.1158/1541-7786.MCR-06-0250.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/1541-7786.MCR-06-0250</ArticleId>
            <ArticleId IdType="pubmed">17374731</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cancer risk and BRCA1 gene mutations. 2021. https://www.facingourrisk.org/info/hereditary-cancer-and-genetic-testing/hereditary-cancer-genes-and-risk/genes-by-name/brca1/cancer-risk Available at:</Citation>
        </Reference>
        <Reference>
          <Citation>Centers for Disease Control and Prevention  . 2021. Coronavirus Disease 2019 (COVID-19)https://www.cdc.gov/coronavirus/2019-ncov/science/science-briefs/vaccine-induced-immunity.html#anchor_1635540449320 [online] Available at:</Citation>
        </Reference>
        <Reference>
          <Citation>Centers for Disease Control and Prevention  . 2021. COVID-19 Booster Shot.https://www.cdc.gov/coronavirus/2019-ncov/vaccines/booster-shot.html [online] Available at:</Citation>
        </Reference>
        <Reference>
          <Citation>Chahar H.S., Bao X., Casola A. Exosomes and their role in the life cycle and pathogenesis of RNA viruses. Viruses. 2015;7:3204–3225. doi: 10.3390/v7062770.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/v7062770</ArticleId>
            <ArticleId IdType="pmc">PMC4488737</ArticleId>
            <ArticleId IdType="pubmed">26102580</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chan K.L., Peng B., Umar M.I., Chan C.Y., Sahakyan A.B., Le M.T.N., Kwok C.K. Structural analysis reveals the formation and role of RNA G-quadruplex structures in human mature microRNAs. Chem. Commun. 2018;54(77):10878–10881. doi: 10.1039/c8cc04635b.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1039/c8cc04635b</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chaudhary N., Weissman D., Whitehead K.A. mRNA vaccines for infectious diseases: principles, delivery and clinical translation. Nat. Rev. Drug Discov. 2021;20:817–838. doi: 10.1038/s41573-021-00283-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41573-021-00283-5</ArticleId>
            <ArticleId IdType="pmc">PMC8386155</ArticleId>
            <ArticleId IdType="pubmed">34433919</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chauvineau‐Grenier A., Bastard P., Servajeank A., Gervais A., Rosain J., Jouanguy E., Cobat A., Casanova J.-L., Rossi B. Autoantibodies neutralizing type I interferons in 20% of COVID‐19 deaths in a French hospital. J. Clin. Immunol. 2022;27 doi: 10.1007/s10875-021-01203-3. January. [Epub ahead of print]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10875-021-01203-3</ArticleId>
            <ArticleId IdType="pmc">PMC8791677</ArticleId>
            <ArticleId IdType="pubmed">35083626</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Choi H.S., Lee H.M., Jang Y.-J., Kim C.-H., Ryua C.J. Heterogeneous nuclear ribonucleoprotein A2/B1 regulates the self-renewal and pluripotency of human embryonic stem cells via the control of the G1/S transition. Stem Cell. 2013;31:2647–2658. doi: 10.1002/stem.1366.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/stem.1366</ArticleId>
            <ArticleId IdType="pubmed">23495120</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Choi Y.E., Pan Y., Park E., Konstantinopoulos P., De S., D'Andrea A., Chowdhury D. MicroRNAs downregulate homologous recombination in the G1 phase of cycling cells to maintain genomic stability. Elife. 2014;3 doi: 10.7554/eLife.02445.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7554/eLife.02445</ArticleId>
            <ArticleId IdType="pmc">PMC4031983</ArticleId>
            <ArticleId IdType="pubmed">24843000</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Choi S., Lee S., Seo J.-W., Kim M.-J., Jeon Y.H., Park J.H., Lee J.K., Yeo N.S. Myocarditis-induced sudden death after BNT162b2 mRNA COVID-19 vaccination in korea: case report focusing on histopathological findings. J. Kor. Med. Sci. 2021;36(40):e286. doi: 10.3346/jkms.2021.36.e286.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3346/jkms.2021.36.e286</ArticleId>
            <ArticleId IdType="pmc">PMC8524235</ArticleId>
            <ArticleId IdType="pubmed">34664804</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cines D.B., Bussel J.B. SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia. N. Engl. J. Med. 2021;384:2254–2256. doi: 10.1056/NEJMe2106315.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMe2106315</ArticleId>
            <ArticleId IdType="pmc">PMC8063912</ArticleId>
            <ArticleId IdType="pubmed">33861524</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Collier D.A., De Marco A., Ferreira I.A.T.M., Meng B., Datir R.P., Walls A.C., et al.  Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies. Nature. 2021;593:136–141. doi: 10.1038/s41586-021-03412-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41586-021-03412-7</ArticleId>
            <ArticleId IdType="pubmed">33706364</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Consoli S., Dono F., Evangelista G., D'Apolito M., Travaglini D., Onofrj M., Bonanni L. Status migrainosus: a potential adverse reaction to Comirnaty (BNT162b2, BioNtech/Pfizer) COVID-19 vaccinea case report. Neurol. Sci. 2021;22:1–4. doi: 10.1007/s10072-021-05741-x. [Epub ahead of print] Nov.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10072-021-05741-x</ArticleId>
            <ArticleId IdType="pmc">PMC8607053</ArticleId>
            <ArticleId IdType="pubmed">34807361</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Créange A. A role for interferon-beta in Guillain-Barré Syndrome? BioDrugs. 2000;14(1):1–11. doi: 10.2165/00063030-200014010-00001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2165/00063030-200014010-00001</ArticleId>
            <ArticleId IdType="pubmed">18034551</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crow A.R., Lazarus A.H. Role of Fcgamma receptors in the pathogenesis and treatment of idiopathic thrombocytopenic purpura. J. Pediatr. Hematol. Oncol. 2003;25(Suppl. 1):S14S18. doi: 10.1097/00043426-200312001-00004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00043426-200312001-00004</ArticleId>
            <ArticleId IdType="pubmed">14668633</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Danese E., Montagnana M., Salvagno G.L., Peserico D., Pighi L., De Nitto S., Henry B.M., Porru S., Lippi G. Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series. Clin. Chem. Lab. Med. 2021;59(9):1585–1591. doi: 10.1515/cclm-2021-0339.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1515/cclm-2021-0339</ArticleId>
            <ArticleId IdType="pubmed">33838087</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Andrea M., Ravera R., Gioia D., Gariglio M., Landolfo S. The interferon system: an overview. Eur. J. Paediatr. Neurol. 2002;6:A41–A46. doi: 10.1053/ejpn.2002.0573.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/ejpn.2002.0573</ArticleId>
            <ArticleId IdType="pubmed">12365360</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Beuckelaer A., Pollard C., Van Lint S., Roose K., Van Hoecke L.V., Naessens T., Udhayakumar V.K., Smet M., Sanders N., Lienenklaus S., et al.  Type I interferons interfere with the capacity of mRNA lipoplex vaccines to elicit cytolytic T cell responses. Mol. Ther. 2016;24(11):2012–2020. doi: 10.1038/mt.2016.161.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/mt.2016.161</ArticleId>
            <ArticleId IdType="pmc">PMC5154477</ArticleId>
            <ArticleId IdType="pubmed">27506450</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Gonzalo-Calvo D., Benítez I.D., Pinilla L., Carratalá A., Moncusí-Moix A., Gort-Paniello C., Molinero M., González J., Torres G., Bernal M., et al.  Circulating microRNA profiles predict the severity of COVID-19 in hospitalized patients. Transl. Res. 2021;236:147–159. doi: 10.1016/j.trsl.2021.05.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.trsl.2021.05.004</ArticleId>
            <ArticleId IdType="pmc">PMC8149473</ArticleId>
            <ArticleId IdType="pubmed">34048985</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Paolis V., Lorefice E., Orecchini E., Carissimi C., Laudadio I., Fulci V. Epitranscriptomics: a new layer of microRNA regulation in cancer. Cancers. 2021;13(13):3372. doi: 10.3390/cancers13133372.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/cancers13133372</ArticleId>
            <ArticleId IdType="pmc">PMC8268402</ArticleId>
            <ArticleId IdType="pubmed">34282776</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Decker C.J., Parker R. P-bodies and stress granules: possible roles in the control of translation and mRNA degradation. Cold Spring Harbor Perspect. Biol. 2012;4(9):a012286. doi: 10.1101/cshperspect.a012286.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/cshperspect.a012286</ArticleId>
            <ArticleId IdType="pmc">PMC3428773</ArticleId>
            <ArticleId IdType="pubmed">22763747</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Delannoy A.S., Hober D., Bouzidi A., Wattre P. Role of interferon alpha (IFN‐α) and interferon gamma (IFN‐γ) in the control of the infection of monocyte‐like cells with Human Cytomegalovirus (HCMV) Microbiol. Immunol. 1999;43(12):1087–1096.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10656176</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dodick D., Silberstein S. Central sensitization theory of migraine: clinical implications. Headache. 2006;46(Suppl. 4):S18291. doi: 10.1111/j.1526-4610.2006.00602.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1526-4610.2006.00602.x</ArticleId>
            <ArticleId IdType="pubmed">17078850</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Doulberis M., Papaefthymiou A., Kotronis G., Gialamprinou D., Soteriades E.S., Kyriakopoulos A., et al.  Does COVID-19 vaccination warrant the classical principle "ofelein i mi vlaptin. Medicina (Kaunas). 2021;57(3):253. doi: 10.3390/medicina57030253.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/medicina57030253</ArticleId>
            <ArticleId IdType="pmc">PMC7999356</ArticleId>
            <ArticleId IdType="pubmed">33803295</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dumortiera J. Liver injury after mRNA-based SARS-CoV-2 vaccination in a liver transplant recipient. Clin. Res. Hepatol. Gastroenterol. 2022;46 doi: 10.1016/j.clinre.2021.101743.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.clinre.2021.101743</ArticleId>
            <ArticleId IdType="pmc">PMC8214934</ArticleId>
            <ArticleId IdType="pubmed">34146727</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dunn G.P., Bruce A.T., Sheehan K.C.F., Shankaran V., Uppaluri R., Bui J.D., Diamond M.S., Koebel C.M., Arthur C., White J.M., et al.  A critical function for type I interferons in cancer immunoediting. Nat. Immunol. 2005;6(7):722–729. doi: 10.1038/ni1213.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ni1213</ArticleId>
            <ArticleId IdType="pubmed">15951814</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Erb H.H., Langlechner R.V., Moser P.L., Handle F., Casneuf T., Verstraeten K., Schlick B., Schäfer G., Hall B., Sasser K., Culig Z., Santer F.R., et al.  IL6 sensitizes prostate cancer to the antiproliferative effect of IFNα2 through IRF9. Endocr. Relat. Cancer. 2013;20(5):677. doi: 10.1530/ERC-13-0222.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1530/ERC-13-0222</ArticleId>
            <ArticleId IdType="pmc">PMC3753051</ArticleId>
            <ArticleId IdType="pubmed">23913484</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Erman A.B., Kejner A.E., Norman B.S., Hogikyan D., Feldman E.L. Disorders of cranial nerves IX and X. Semin. Neurol. 2009;29(1):8592. doi: 10.1055/s-0028-1124027.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-0028-1124027</ArticleId>
            <ArticleId IdType="pmc">PMC4239699</ArticleId>
            <ArticleId IdType="pubmed">19214937</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eviston T., Croxson G.R., Kennedy P.G.E., Hadlock T., Krishnan A.V. Bell's palsy: aetiology, clinical features and multidisciplinary care. J. Neurol. Neurosurg. Psychiatry. 2015;86 doi: 10.1136/jnnp-2014-309563.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jnnp-2014-309563</ArticleId>
            <ArticleId IdType="pubmed">25857657</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Farazi T.A., Hoell J.I., Morozov P., Tuschl T. MicroRNAs in human cancer. Adv. Exp. Med. Biol. 2013;774:1–20. doi: 10.1007/978-94-007-5590-1_1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/978-94-007-5590-1_1</ArticleId>
            <ArticleId IdType="pmc">PMC3704221</ArticleId>
            <ArticleId IdType="pubmed">23377965</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fathy R.A., McMahon D.E., Lee C., Chamberlin G.C., Rosenbach M., Lipoff J.B., Tyagi A., Desai S.R., French L.E., Lim H.W., et al.  Varicella-zoster and herpes simplex virus reactivation post-COVID-19 vaccination: a review of 40 cases in an International Dermatology Registry. JEADV. 2022;36(1):e6–e9. doi: 10.1111/jdv.17646.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jdv.17646</ArticleId>
            <ArticleId IdType="pmc">PMC8656951</ArticleId>
            <ArticleId IdType="pubmed">34487581</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fay M.M., Lyons S.M., Ivanov P. RNA G-quadruplexes in biology: principles and molecular mechanisms. J. Mol. Biol. 2017;429(14):2127–2147. doi: 10.1016/j.jmb.2017.05.017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jmb.2017.05.017</ArticleId>
            <ArticleId IdType="pmc">PMC5603239</ArticleId>
            <ArticleId IdType="pubmed">28554731</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>FDA  . Vaccines and Related Biological Products Advisory Committee December 10, 2020 Meeting Announcement. 2021. https://www.fda.gov/advisory-committees/advisory-committee-calendar/vaccines-and-related-biological-products-advisory-committee-december-10-2020-meeting- announcement</Citation>
        </Reference>
        <Reference>
          <Citation>FDA  . Vaccines and Related Biological Products Advisory Committee December 17, 2020 Meeting Announcement. 2021. https://www.fda.gov/advisory-committees/advisory-committee-calendar/vaccines-and-related-biological-products-advisory-committee-december-17-2020-meeting-announcement</Citation>
        </Reference>
        <Reference>
          <Citation>Feng B., Eknoyan G., Guo Z.S., Jadoul M., Rao H.Y., Zhang W., Wei L. Effect of interferon- alpha-based antiviral therapy on hepatitis C virus-associated glomerulonephritis: a meta-analysis. Nephrol. Dial. Transplant. 2012;27(2):640–646.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21558431</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fenton A.M., Hammill S.C., Rea R.F., Low P.A., Shen W.-K. Vasovagal syncope. Ann. Intern. Med. 2000;133(9):714–725. doi: 10.7326/0003-4819-133-9-200011070-00014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7326/0003-4819-133-9-200011070-00014</ArticleId>
            <ArticleId IdType="pubmed">11074905</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Finnberg N.K., El-Deiry W.S. TRAIL death receptors as tumor suppressors and drug targets. Cell Cycle. 2008;7(11):1525–1528. doi: 10.4161/cc.7.11.5975.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4161/cc.7.11.5975</ArticleId>
            <ArticleId IdType="pubmed">18469516</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Forni G., Mantovani A. COVID-19 Commission of Accademia Nazionale dei Lincei, Rome. COVID-19 vaccines: where we stand and challenges ahead. Cell Death Differ. 2021;28(2):626–639. doi: 10.1038/s41418-020-00720-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41418-020-00720-9</ArticleId>
            <ArticleId IdType="pmc">PMC7818063</ArticleId>
            <ArticleId IdType="pubmed">33479399</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garg A., Seeliger B., Derda A.A., Xiao K., Gietz A., Scherf K., Sonnenschein K., Pink I., Hoeper M.M., Welte T., et al.  Circulating cardiovascular microRNAs in critically ill COVID-19 patients. Eur. J. Heart Fail. 2021;23(3):468–475. doi: 10.1002/ejhf.2096.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ejhf.2096</ArticleId>
            <ArticleId IdType="pmc">PMC8014268</ArticleId>
            <ArticleId IdType="pubmed">33421274</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gavras I., Gavras H. Angiotensin II as a cardiovascular risk factor. J. Hum. Hypertens. 2002;16(Suppl. 2):S2–S6. doi: 10.1038/sj.jhh.1001392.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.jhh.1001392</ArticleId>
            <ArticleId IdType="pubmed">11967726</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Girardi T., De Keersmaecker K. T-ALL: ALL a matter of translation? Haematologica. 2015;100(3):293–295. doi: 10.3324/haematol.2014.118562.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3324/haematol.2014.118562</ArticleId>
            <ArticleId IdType="pmc">PMC4349265</ArticleId>
            <ArticleId IdType="pubmed">25740104</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goldman S., Bron D., Tousseyn T., Vierasu I., Dewispelaere L., Heimann P., Cogan E., Goldman M. Rapid progression of angioimmunoblastic T cell lymphoma following BNT162b2 mRNA vaccine booster shot: a case report. Front. Med. 2021;8 doi: 10.3389/fmed.2021.798095.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fmed.2021.798095</ArticleId>
            <ArticleId IdType="pmc">PMC8656165</ArticleId>
            <ArticleId IdType="pubmed">34901098</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gordon D.E., Hiatt J., Bouhaddou M., Rezelj V.V., Ulferts S., Braberg H., et al.  Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. Science. 2020;370(6521) doi: 10.1126/science.abe9403.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.abe9403</ArticleId>
            <ArticleId IdType="pmc">PMC7808408</ArticleId>
            <ArticleId IdType="pubmed">33060197</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gould F.D.H., Lammers A.R., Mayer C.J., German R.Z. Specific vagus nerve lesion have distinctive physiologic mechanisms of dysphagia. Front. Neurol. 2019;10:1301. doi: 10.3389/fneur.2019.01301.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fneur.2019.01301</ArticleId>
            <ArticleId IdType="pmc">PMC6920241</ArticleId>
            <ArticleId IdType="pubmed">31920925</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guo X., Namekata K., Kimura A., Harada C., Harada T. The renin-angiotensin system regulates neurodegeneration in a mouse model of optic neuritis. Am. J. Pathol. 2017;187(12):2876–2885. doi: 10.1016/j.ajpath.2017.08.012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajpath.2017.08.012</ArticleId>
            <ArticleId IdType="pubmed">28919108</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hadjadj J., Yatim N., Barnabei L., Corneau A., Boussier J., Smith N., Péré H., Charbit B., Bondet V., Chenevier-Gobeaux C., et al.  Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science. 2020;369(6504):718–724. doi: 10.1016/j.cell.2020.04.026.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2020.04.026</ArticleId>
            <ArticleId IdType="pmc">PMC7402632</ArticleId>
            <ArticleId IdType="pubmed">32661059</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Han S.H., Choe J. Diverse molecular functions of m6A mRNA modification in cancer. Exp. Mol. Med. 2020;52(5):738–749. doi: 10.1038/s12276-020-0432-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s12276-020-0432-y</ArticleId>
            <ArticleId IdType="pmc">PMC7272606</ArticleId>
            <ArticleId IdType="pubmed">32404927</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heise R., Amann P.M., Ensslen S., Marquardt Y., Czaja K., Joussen S., Beer D., Abele R., Plewnia G., Tampé R., et al.  Interferon alpha signaling and its relevance for the upregulatory effect of transporter proteins associated with antigen processing (TAP) in patients with malignant melanoma. PLoS One. 2016;11(1) doi: 10.1371/journal.pone.0146325.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0146325</ArticleId>
            <ArticleId IdType="pmc">PMC4703378</ArticleId>
            <ArticleId IdType="pubmed">26735690</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Herdy B., Mayer C., Varshney D., Marsico G., Murat P., Taylor C., D'Santos C., Tannahill D., Balasubramanian S. Analysis of NRAS RNA G-quadruplex binding proteins reveals DDX3X as a novel interactor of cellular G-quadruplex containing transcripts. Nucleic Acids Res. 2018;46(21):11592–11604. doi: 10.1093/nar/gky861.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/nar/gky861</ArticleId>
            <ArticleId IdType="pubmed">0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoagland D.A., Møller R., Uhl S.A., Oishi K., Frere J., Golynker T., Horiuchi S., Panis M., Blanco-Melo D., Sachs D., et al.  Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity. Immunity. 2021;54 doi: 10.1016/j.immuni.2021.01.017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.immuni.2021.01.017</ArticleId>
            <ArticleId IdType="pmc">PMC7846242</ArticleId>
            <ArticleId IdType="pubmed">33577760</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Honda K., Takaoka A., Taniguchi T. Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity. 2006;25(3):349–360. doi: 10.1016/j.immuni.2006.08.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.immuni.2006.08.009</ArticleId>
            <ArticleId IdType="pubmed">16979567</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Honke K. Biosynthesis and biological function of sulfoglycolipids. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 2013;89(4) doi: 10.2183/pjab.89.129.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2183/pjab.89.129</ArticleId>
            <ArticleId IdType="pmc">PMC3669731</ArticleId>
            <ArticleId IdType="pubmed">23574804</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hou X., Zaks T., Langer R., Dong Y. Lipid nanoparticles for mRNA delivery. Nat. Rev. Mater. 2021;6:1078–1094. doi: 10.1038/s41578-021-00358-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41578-021-00358-0</ArticleId>
            <ArticleId IdType="pmc">PMC8353930</ArticleId>
            <ArticleId IdType="pubmed">34394960</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang Y., Cai X., Song X., Tang H., Huang Y., Xie S., Hu Y. Steroids for preventing recurrence of acute severe migraine headaches: a meta-analysis. Eur. J. Neurol. 2013;20(8):1184–1190. doi: 10.1111/ene.12155.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/ene.12155</ArticleId>
            <ArticleId IdType="pubmed">23577697</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang F.T., Sun J., Zhang L., He X., Zhu Y.H., Dong H.J., Wang H.-Y., Zhu L., Zou Huang J.W., et al.  Role of SIRT1 in hematologic malignancies. J. Zhejiang Univ. - Sci. B. 2019;20(5):391–398. doi: 10.1631/jzus.B1900148.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1631/jzus.B1900148</ArticleId>
            <ArticleId IdType="pmc">PMC6568226</ArticleId>
            <ArticleId IdType="pubmed">31090265</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ilyas A.A., Mithen F.A., Dalakas M.C., Wargo M., Chen Z.W., Bielory L., Cook S.D. Antibodies to sulfated glycolipids in Guillain-Barr syndrome. J. Neurol. Sci. 1991;105(1):108–117. doi: 10.1016/0022-510x(91)90126-r.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0022-510x(91)90126-r</ArticleId>
            <ArticleId IdType="pubmed">1795163</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ivanova E.N., Devlin J.C., Buus T.B., Koide A., Cornelius A., Samanovic M.I., Herrera A., Zhang C., Desvignes L., Odum N., Ulrich R., Mulligan M.J., Koide S., Ruggles K.V., Herati R.S., Koralov S.B. Discrete immune response signature to SARS-CoV-2 mRNA vaccination versus infection. medRxiv preprint. 2021 doi: 10.1101/2021.04.20.21255677. April 21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/2021.04.20.21255677</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iwanaga J., Fukuoka H., Fukuoka N., Yutori H., Ibaragi S., Tubbs R.S. A narrative review and clinical anatomy of Herpes zoster infection following COVID‐19 vaccination. Clin. Anat. 2021;35(1):45–51. doi: 10.1002/ca.23790.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ca.23790</ArticleId>
            <ArticleId IdType="pmc">PMC8652627</ArticleId>
            <ArticleId IdType="pubmed">34554601</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jain S.S., Steele J.M., Fonseca B., Huang S., Shah S., Maskatia S.A., Buddhe S., Misra N., Ramachandran P., Gaur L., et al.  COVID-19 vaccination–associated myocarditis in adolescents. Pediatrics. 2021;148(5) doi: 10.1542/peds.2021-053427.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1542/peds.2021-053427</ArticleId>
            <ArticleId IdType="pubmed">34389692</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Janeway C.A., Jr., Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 2002;20:197–216. doi: 10.1146/annurev.immunol.20.083001.084359.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev.immunol.20.083001.084359</ArticleId>
            <ArticleId IdType="pubmed">11861602</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jang S.K., Pestova T.V., Hellen C.U.T., Witherell G.W., Wimmer E. Cap-independent translation of picornavirus RNAs: structure and function of the internal ribosomal entry site. Enzyme. 1990;44:292–309. doi: 10.1159/000468766.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000468766</ArticleId>
            <ArticleId IdType="pubmed">1966843</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jaubert C., Bedrat A., Bartolucci L., Di Primo C., Ventura M., Mergny J.-L., Amrane S., Andreola M.-L. RNA synthesis is modulated by G-quadruplex formation in Hepatitis C virus negative RNA strand. Sci. Rep. 2018;8:8120. doi: 10.1038/s41598-018-26582-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-018-26582-3</ArticleId>
            <ArticleId IdType="pmc">PMC5970142</ArticleId>
            <ArticleId IdType="pubmed">29802381</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jego G.A., Palucka K., Blanck J.-P., Chalouni C., Pascual V., Banchereau J. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity. 2003;19 doi: 10.1016/s1074-7613(03)00208-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s1074-7613(03)00208-5</ArticleId>
            <ArticleId IdType="pubmed">12932356</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jeong M., Ocwieja K.E., Han D., Wackym P.A., Zhang Y., Brown A., Moncada C., Vambutas A., Kanne T., Crain R., et al.  Direct SARS-CoV-2 infection of the human inner ear may underlie COVID-19-associated audiovestibular dysfunction. Commun. Med. 2021;1:44. doi: 10.1038/s43856-021-00044-w.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s43856-021-00044-w</ArticleId>
            <ArticleId IdType="pmc">PMC8633908</ArticleId>
            <ArticleId IdType="pubmed">34870285</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jhaveri R. The COVID-19 mRNA vaccines and the pandemic: do they represent the beginning of the end or the end of the beginning? Clin. Therapeut. 2021;43(3):549–556. doi: 10.1016/j.clinthera.2021.01.014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.clinthera.2021.01.014</ArticleId>
            <ArticleId IdType="pmc">PMC7825996</ArticleId>
            <ArticleId IdType="pubmed">33579547</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jiang H., Mei Y.-F. SARS-CoV-2 spike impairs DNA damage repair and inhibits V(D)J recombination in vitro. Viruses. 2021;13(2056) doi: 10.3390/v13102056.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/v13102056</ArticleId>
            <ArticleId IdType="pmc">PMC8538446</ArticleId>
            <ArticleId IdType="pubmed">34696485</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kaczmarek R., El Ekiaby M., Hart D.P., Hermans C., Makris M., Noone D., O'Mahony B., Page D., Peyvandi F., Pipe S.W., et al.  Vaccination against COVID‐19: rationale, modalities and precautions for patients with haemophilia and other inherited bleeding disorders. Haemophilia. 2021;27(4):515–518. doi: 10.1111/hae.14271.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/hae.14271</ArticleId>
            <ArticleId IdType="pmc">PMC8014441</ArticleId>
            <ArticleId IdType="pubmed">33651911</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kakarougkas A., Ismail A., Klement K., Goodarzi A.A., Conrad S., Freire R., Shibata A., Lobrich M., Jeggo P.A. Opposing roles for 53BP1 during homologous recombination. Nucleic Acids Res. 2013;41(21):9719–9731. doi: 10.1093/nar/gkt729.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/nar/gkt729</ArticleId>
            <ArticleId IdType="pmc">PMC3834810</ArticleId>
            <ArticleId IdType="pubmed">23969417</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kalra R.S., Kandimalla R. Engaging the spikes: heparan sulfate facilitates SARS-CoV-2 spike protein binding to ACE2 and potentiates viral infection. Signal Transduct. Targeted Ther. 2021;6:39. doi: 10.1038/s41392-021-00470-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41392-021-00470-1</ArticleId>
            <ArticleId IdType="pmc">PMC7844799</ArticleId>
            <ArticleId IdType="pubmed">33514685</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kampf G. The epidemiological relevance of the COVID-19-vaccinated population is increasing. Lancet. Reg. Health – Europ. 2021;11 doi: 10.1016/j.lanepe.2021.100272.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.lanepe.2021.100272</ArticleId>
            <ArticleId IdType="pmc">PMC8604656</ArticleId>
            <ArticleId IdType="pubmed">34841383</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kampf G. The epidemiological relevance of the COVID-19-vaccinated population is increasing. Lancet Reg. Health - Europ. 2021;11 doi: 10.1016/j.lanepe.2021.100272.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.lanepe.2021.100272</ArticleId>
            <ArticleId IdType="pmc">PMC8604656</ArticleId>
            <ArticleId IdType="pubmed">34841383</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karikó K., Buckstein M., Ni H., Weissman D. Suppression of RNA recognition by toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity. 2005;23 doi: 10.1016/j.immuni.2005.06.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.immuni.2005.06.008</ArticleId>
            <ArticleId IdType="pubmed">16111635</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Katalin Karikó K., Muramatsu H., Welsh F.A., Ludwig J., Kato H., Akira S., Weissman D. Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Mol. Ther. 2008;16:1833–1840. doi: 10.1038/mt.2008.200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/mt.2008.200</ArticleId>
            <ArticleId IdType="pmc">PMC2775451</ArticleId>
            <ArticleId IdType="pubmed">18797453</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Katsikas Triantafyllidis K., Giannos P., Mian I.T., Kyrtsonis G., Kechagias K.S. Varicella zoster virus reactivation following COVID-19 vaccination: a systematic review of case reports. Vaccines. 2021;9(9):1013. doi: 10.3390/vaccines9091013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/vaccines9091013</ArticleId>
            <ArticleId IdType="pmc">PMC8471236</ArticleId>
            <ArticleId IdType="pubmed">34579250</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kaulen L.D., Doubrovinskaia S., Mooshage C., Jordan B., Purrucker J., Haubner C., Seliger C., Lorenz H.-M., Nagel S., Wildemann B., Bendszus M., Wick W., Schnenberger S. Neurological autoimmune diseases following vaccinations against SARS-CoV-2: a case series. Eur. J. Neurol. 2021:1–9. doi: 10.1111/ene.15147. [Epub ahead of print]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/ene.15147</ArticleId>
            <ArticleId IdType="pmc">PMC8652629</ArticleId>
            <ArticleId IdType="pubmed">34668274</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kaur A., Fang C.M. An overview of the human immune system and the role of interferon regulatory factors (IRFs) Prog. Microb. Mol. Biol. 2020;3(1) doi: 10.36877/pmmb.a0000129. 2020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.36877/pmmb.a0000129</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kelton J.G., Arnold D.M., Nazy I. Lessons from vaccine-induced immune thrombotic thrombocytopenia. Nat. Rev. Immunol. 2021;21(12):753–755. doi: 10.1038/s41577-021-00642-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41577-021-00642-8</ArticleId>
            <ArticleId IdType="pmc">PMC8521503</ArticleId>
            <ArticleId IdType="pubmed">34663971</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khayat-Khoei M., Bhattacharyya S., Katz J., Harrison D., Tauhid S., Bruso P., Houtchens M.K., Edwards K.R., Bakshi R. COVID-19 mRNA vaccination leading to CNS inflammation: a case series. J. Neurol. 2021 Sep 4:1–14. doi: 10.1007/s00415-021-10780-7. [Epub ahead of print]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00415-021-10780-7</ArticleId>
            <ArticleId IdType="pmc">PMC8417681</ArticleId>
            <ArticleId IdType="pubmed">34480607</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kimura T., Nakajima T., Kamijo Y., Tanaka N., Wang L., Hara A., Sugiyama E., Tanaka E., Gonzalez F.J., Aoyama T. Hepatic cerebroside sulfotransferase is induced by PPAR activation in mice. PPAR Res. 2012 doi: 10.1155/2012/174932. 2012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2012/174932</ArticleId>
            <ArticleId IdType="pmc">PMC3356938</ArticleId>
            <ArticleId IdType="pubmed">22645601</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Knuckles P., Bühler M. Adenosine methylation as a molecular imprint defining the fate of RNA. FEBS Lett. 2018;592(17):2845–2859. doi: 10.1002/1873-3468.13107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/1873-3468.13107</ArticleId>
            <ArticleId IdType="pmc">PMC6175371</ArticleId>
            <ArticleId IdType="pubmed">29782652</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kolumam G.A., Thomas S., Thompson L.J., Sprent J., Murali-Krishna K. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J. Exp. Med. 2005;202(5) doi: 10.1084/jem.20050821.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.20050821</ArticleId>
            <ArticleId IdType="pmc">PMC2212878</ArticleId>
            <ArticleId IdType="pubmed">16129706</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koo J.W., Russo S.J., Ferguson D., Nestler E.J., Duman R.S. Nuclear factor-kappaB is a critical mediator of stress-impaired neurogenesis and depressive behavior. Proc. Natl. Acad. Sci. U. S. A. 2010;107(6):2669–2674. doi: 10.1073/pnas.0910658107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0910658107</ArticleId>
            <ArticleId IdType="pmc">PMC2823860</ArticleId>
            <ArticleId IdType="pubmed">20133768</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kothandan V.K., Kothandan S., Kim D.H., Byun Y., Lee Y.-K., Park I.-K., Hwang S.R. Crosstalk between stress granules, exosomes, tumour antigens, and immune cells: significance for cancer immunity. Vaccines. 2020;8(2):172. doi: 10.3390/vaccines8020172.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/vaccines8020172</ArticleId>
            <ArticleId IdType="pmc">PMC7349635</ArticleId>
            <ArticleId IdType="pubmed">32276342</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kudla G., Lipinski L., Caffin F., Helwak A., Zylicz M. High guanine and cytosine content increases mRNA levels in mammalian cells. PLoS Biol. 2006;4(6) doi: 10.1371/journal.pbio.0040180.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pbio.0040180</ArticleId>
            <ArticleId IdType="pmc">PMC1463026</ArticleId>
            <ArticleId IdType="pubmed">16700628</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuwahara M., Kusunoki S. Mechanism and spectrum of anti-glycolipid antibody-mediated chronic inflammatory demyelinating polyneuropathy. Clin. Exper. Neuroimmunol. 2018;9(1):65–74. doi: 10.1111/cen3.12452.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/cen3.12452</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kwok H.F. Review of COVID-19 vaccine clinical trials -- A puzzle with missing pieces. Int. J. Biol. Sci. 2021;7(6):1461.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8071768</ArticleId>
            <ArticleId IdType="pubmed">33907509</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kyriakopoulos A.M., McCullough P.A. Synthetic mRNAs; their analogue caps and contribution to disease. Diseases. 2021;9(3):57. doi: 10.3390/diseases9030057.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/diseases9030057</ArticleId>
            <ArticleId IdType="pmc">PMC8395722</ArticleId>
            <ArticleId IdType="pubmed">34449596</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lanz T.V., Ding Z., Ho P.P., Luo J., Agrawal A.N., Srinagesh H., Axtell R., Zhang H., Platten M., Wyss-Coray T., Steinman L. Angiotensin II sustains brain inflammation in mice via TGF-beta. J. Clin. Invest. 2010;120(8):2782–2794. doi: 10.1172/JCI41709.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI41709</ArticleId>
            <ArticleId IdType="pmc">PMC2912186</ArticleId>
            <ArticleId IdType="pubmed">20628203</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lazarus R., Klompas M., Bernstein S.  2010. Electronic Support for Public Health–Vaccine Adverse Event Reporting System (ESP: VAERS). Grant. Final Report, Grant ID: R18 HS; p. 17045.</Citation>
        </Reference>
        <Reference>
          <Citation>Lee E.-J., Cines D.B., Gernsheimer T., Kessler C., Michel M., Tarantino M.D., Semple J.W., Arnold D.M., Godeau B., Lambert M.P., Bussel J.B. Thrombocytopenia following pfizer and Moderna SARS-CoV-2 vaccination. Am. J. Hematol. 2021;96(5):534–537.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8014568</ArticleId>
            <ArticleId IdType="pubmed">33606296</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lemberger T., Staels B., Saladin R., Desvergne B., Auwerx J., Wahli W. Regulation of the peroxisome proliferator-activated receptor alpha gene by glucocorticoids. J. Biol. Chem. 1994;269(40):24527–24530. doi: 10.1093/toxsci/kfn260.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/toxsci/kfn260</ArticleId>
            <ArticleId IdType="pubmed">7929119</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lensen R., Netea M.G., Rosendaal F.R. Hepatitis C virus reactivation following COVID-19 vaccination -- A case report. Int. Med. Case Rep. J. 2021;14:573–575. doi: 10.2147/IMCRJ.S328482.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/IMCRJ.S328482</ArticleId>
            <ArticleId IdType="pmc">PMC8412816</ArticleId>
            <ArticleId IdType="pubmed">34512037</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Letarov A.V., Babenko V.V., Kulikov E.E. Free SARS-CoV-2 spike protein S1 particles may play a role in the pathogenesis of COVID-19 infection. Biochemistry (Mosc.) 2021;86(3):257–261. doi: 10.1134/S0006297921030032.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1134/S0006297921030032</ArticleId>
            <ArticleId IdType="pmc">PMC7772528</ArticleId>
            <ArticleId IdType="pubmed">33838638</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leung D.W., Amarasinghe G.K. When your cap matters: structural insights into self vs non-self recognition of 5' RNA by immunomodulatory host proteins. Curr. Opin. Struct. Biol. 2016;36:133–141. doi: 10.1016/j.sbi.2016.02.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.sbi.2016.02.001</ArticleId>
            <ArticleId IdType="pmc">PMC5218996</ArticleId>
            <ArticleId IdType="pubmed">26916433</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Y., Huang R., Wang L., Hao J., Zhang Q., Ling R., Yun J. Micro RNA‐762 promotes breast cancer cell proliferation and invasion by targeting IRF7 expression. Cell Prolif. 2015;48(6):643–649. doi: 10.1111/cpr.12223.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/cpr.12223</ArticleId>
            <ArticleId IdType="pmc">PMC6496530</ArticleId>
            <ArticleId IdType="pubmed">26597380</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lindenmann J. From interference to interferon: a brief historical introduction. Philos. Trans. R. Soc. Lond. B Biol. Sci. 1982;299(1094):3–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6183693</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu T., Khanna K.M., Chen X., Fink D.J., Hendricks R.L. CD8(+) T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons. J. Exp. Med. 2000;191(9):1459–1466. doi: 10.1084/jem.191.9.1459.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.191.9.1459</ArticleId>
            <ArticleId IdType="pmc">PMC2213436</ArticleId>
            <ArticleId IdType="pubmed">10790421</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu J., Wang J., Xu J., Xia H., Wang Y., Zhang C., Chen W., Zhang H., Liu Q., Zhu R., et al.  Comprehensive investigations revealed consistent pathophysiological alterations after vaccination with COVID-19 vaccines. Cell Discov. 2021;7(1):99. doi: 10.1038/s41421-021-00329-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41421-021-00329-3</ArticleId>
            <ArticleId IdType="pmc">PMC8546144</ArticleId>
            <ArticleId IdType="pubmed">34697287</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lladó I., Fernández-Bernáldez A., Rodríguez-Jiménez P. Varicella zoster virus reactivation and mRNA vaccines as a trigger. JAAD. Case Rep. 2021;15:62–63. doi: 10.1016/j.jdcr.2021.07.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jdcr.2021.07.011</ArticleId>
            <ArticleId IdType="pmc">PMC8298014</ArticleId>
            <ArticleId IdType="pubmed">34316507</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lu Y., Harada M., Kamijo Y., Nakajima T., Tanaka N., Sugiyama E., Kyogashima M., Gonzalez F.J., Aoyama T. Peroxisome proliferator-activated receptor attenuates high-cholesterol diet-induced toxicity and pro-thrombotic effects in mice. Arch. Toxicol. 2019;93(1) doi: 10.1007/s00204-018-2335-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00204-018-2335-4</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>MacFarlane M., Kohlhaas S.L., Sutcliffe M.J., Dyer M.J., Cohen G.M. TRAIL receptor-selective mutants signal to apoptosis via TRAIL-R1 in primary lymphoid malignancies. Cancer Res. 2005;65(24):11265–11270. doi: 10.1158/0008-5472.CAN-05-2801.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-05-2801</ArticleId>
            <ArticleId IdType="pubmed">16357130</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maleki A. COVID-19 recombinant mRNA vaccines and serious ocular inflammatory side effects: real or coincidence? J. Ophthalmic Vis. Res. 2021;16(3) doi: 10.18502/jovr.v16i3.9443.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.18502/jovr.v16i3.9443</ArticleId>
            <ArticleId IdType="pmc">PMC8358769</ArticleId>
            <ArticleId IdType="pubmed">34394876</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mann R., Sekhon S., Sekhon S. Drug-induced liver injury after COVID-19 vaccine. Cureus. 2021;13(7) doi: 10.7759/cureus.16491.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7759/cureus.16491</ArticleId>
            <ArticleId IdType="pmc">PMC8372667</ArticleId>
            <ArticleId IdType="pubmed">34430106</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marcus J., Honigbaum S., Shroff S., Honke K., Rosenbluth J., Dupree J.L. Sulfatide is essential for the maintenance of CNS myelin and axon structure. Glia. 2006;53(4):372–381. doi: 10.1002/glia.20292.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/glia.20292</ArticleId>
            <ArticleId IdType="pubmed">16288467</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martini P.G.V., Guey L.T. A new era for rare genetic diseases: messenger RNA therapy. Hum. Gene Ther. 2019;30(10):1180–1189. doi: 10.1089/hum.2019.090.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/hum.2019.090</ArticleId>
            <ArticleId IdType="pubmed">31179759</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matsuoka M., Tani K., Asano S. Interferon-alpha-induced G1 phase arrest through upregulated expression of CDK inhibitors, p19Ink4D and p21Cip1 in mouse macrophages. Oncogene. 1998;16:2075–2086. doi: 10.1038/sj.onc.1201745.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.onc.1201745</ArticleId>
            <ArticleId IdType="pubmed">9572488</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mauro V.P., Chappell S.A. A critical analysis of codon optimization in human therapeutics. Trends Mol. Med. 2014;20(11):604–613. doi: 10.1016/j.molmed.2014.09.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.molmed.2014.09.003</ArticleId>
            <ArticleId IdType="pmc">PMC4253638</ArticleId>
            <ArticleId IdType="pubmed">25263172</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McCarthy C., Carrea A., Diambra L. Bicodon bias can determine the role of synonymous SNPs in human diseases. BMC Genom. 2017;18(1):227. doi: 10.1186/s12864-017-3609-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12864-017-3609-6</ArticleId>
            <ArticleId IdType="pmc">PMC5347174</ArticleId>
            <ArticleId IdType="pubmed">28288557</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McKenzie S.E., Taylor S.M., Malladi P., Yuhan H., Cassel D.L., Chien P., Schwartz E., Schreiber A.D., Surrey S., Reilly M.P. The role of the human Fc receptor FcRIIA in the immune clearance of platelets: a transgenic mouse model. J. Immunol. 1999;162:4311–4318. http://www.jimmunol.org/content/162/7/4311</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10201963</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McKernan K., Kyriakopoulos A.M., McCullough P.A. Differences in vaccine and SARS-CoV-2 replication derived mRNA: implications for cell biology and future disease. OSF Prepr. 2021 doi: 10.31219/osf.io/bcsa6. November 26.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.31219/osf.io/bcsa6</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McLachlan S., Osman M., Dube K., Chiketero P., Choi Y., Fenton N. Analysis of COVID-19 vaccine death reports from the vaccine adverse events reporting system (VAERS) database. Preprint. 2021 doi: 10.13140/RG.2.2.26987.26402.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.13140/RG.2.2.26987.26402</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meyer K.D., Patil D.P., Zhou J., Zinoviev A., Skabkin M.A., Elemento O., Pestova T.V., Qian S.-B., Jaffrey S.R. 5' UTR m(6)A promotes cap-independent translation. Cell. 2015;163(4):999–1010. doi: 10.1016/j.cell.2015.10.012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2015.10.012</ArticleId>
            <ArticleId IdType="pmc">PMC4695625</ArticleId>
            <ArticleId IdType="pubmed">26593424</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mishra R., Banerjea A.C. SARS-CoV-2 Spike targets USP33-IRF9 axis via exosomal miR-148a to activate human microglia. Front. Immunol. 2021;12 doi: 10.3389/fimmu.2021.656700.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2021.656700</ArticleId>
            <ArticleId IdType="pmc">PMC8079643</ArticleId>
            <ArticleId IdType="pubmed">33936086</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mittal M.K., Chaudhuri G.  Abstracts: First AACR International Conference on Frontiers in Basic Cancer Research--Oct 8–11, 2009. Boston, MA. 2009. https://cancerres.aacrjournals.org/content/69/23_Supplement/A16.short</Citation>
        </Reference>
        <Reference>
          <Citation>Mulligan M.J., Lyke K.E., Kitchin N., Absalon J., Gurtman A., Lockhart S., Neuzil K., Raabe V., Bailey R., Swanson K.A., Li P., Koury K., Kalina W., Cooper D., Fontes-Garfias C., Shi P.-Y., Türeci Ö., Tompkins K.R., Walsh E.E., Frenck R., Falsey A.R., Dormitzer P.R., Gruber W.C., Şahin U., Jansen K.U. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature. 2020;586(7830):589–593. doi: 10.1038/s41586-020-2639-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41586-020-2639-4</ArticleId>
            <ArticleId IdType="pubmed">32785213</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mungoven T.J., Meylakh N., Marciszewski K.K., Macefield V.G., Macey P.M., Henderson L.A. Microstructural changes in the trigeminal nerve of patients with episodic migraine assessed using magnetic resonance imaging. J. Headache Pain. 2020;21:59. doi: 10.1186/s10194-020-01126-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s10194-020-01126-1</ArticleId>
            <ArticleId IdType="pmc">PMC7260805</ArticleId>
            <ArticleId IdType="pubmed">32471359</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Musella M., Manic G., de Maria R., Vitale I., Sistigue A. Type-I-interferons in infection and cancer: unanticipated dynamics with therapeutic implications. OncoImmunology. 2017;6(5) doi: 10.1080/2162402X.2017.1314424.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/2162402X.2017.1314424</ArticleId>
            <ArticleId IdType="pmc">PMC5467995</ArticleId>
            <ArticleId IdType="pubmed">28638743</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nandha R., Singh H. Renin angiotensin system: a novel target for migraine prophylaxis. Indian J. Pharmacol. 2012;44(2) doi: 10.4103/0253-7613.93840.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4103/0253-7613.93840</ArticleId>
            <ArticleId IdType="pmc">PMC3326904</ArticleId>
            <ArticleId IdType="pubmed">22529467</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>National Cancer Institute  BRCA gene mutations: cancer risk and genetic testing fact sheet. 2021. https://www.cancer.gov/about-cancer/causes-prevention/genetics/brca-fact-sheet#what-other-cancers-are-linked-to-harmful-variants-in-brca1-and-brca2 [online] Available at:</Citation>
        </Reference>
        <Reference>
          <Citation>Nevzorova T.A., Mordakhanova E.R., Daminova A.G., Ponomareva A.A., Andrianova I.A., Minh G.L., Rauova L., Litvinov R.L., Weisel J.W. Platelet factor 4-containing immune complexes induce platelet activation followed by calpain-dependent platelet death. Cell Death Dis. 2019;5:106. doi: 10.1038/s41420-019-0188-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41420-019-0188-0</ArticleId>
            <ArticleId IdType="pmc">PMC6591288</ArticleId>
            <ArticleId IdType="pubmed">31263574</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Olsthoorn R.C. G-quadruplexes within prion mRNA: the missing link in prion disease? Nucleic Acids Res. 2014;42:9327–9333. doi: 10.1093/nar/gku559.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/nar/gku559</ArticleId>
            <ArticleId IdType="pmc">PMC4132711</ArticleId>
            <ArticleId IdType="pubmed">25030900</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Orlandini von Niessen A.G., Poleganov M.A., Rechner C., Plaschke A., Kranz L.M., Fesser S., Diken M., Löwer M., Vallazza B., Beissert T., et al.  Improving mRNA-based therapeutic gene delivery by expression-augmenting 3’ UTRs identified by cellular library screening. Mol. Ther. 2019;27(4):824–836. doi: 10.1016/j.ymthe.2018.12.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ymthe.2018.12.011</ArticleId>
            <ArticleId IdType="pubmed">0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Otsuka H., Fukao A., Funakami Y., Duncan K.E., Fujiwara T. Emerging evidence of translational control by AU-rich element-binding proteins. Front. Genet. 2019;10:332. doi: 10.3389/fgene.2019.00332.g.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fgene.2019.00332.g</ArticleId>
            <ArticleId IdType="pmc">PMC6507484</ArticleId>
            <ArticleId IdType="pubmed">31118942</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oudit G.Y., Kassiri Z., Jiang C., Liu P.P., Poutanen S.M., Penninger J.M., Butany J. SARS coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur. J. Clin. Invest. 2009;39(7) doi: 10.1111/j.1365-2362.2009.02153.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2362.2009.02153</ArticleId>
            <ArticleId IdType="pmc">PMC7163766</ArticleId>
            <ArticleId IdType="pubmed">19453650</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ozaki T., Nakagawara A. Role of p53 in cell death and human cancers. Cancers. 2011;3(1):994–1013. doi: 10.3390/cancers3010994.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/cancers3010994</ArticleId>
            <ArticleId IdType="pmc">PMC3756401</ArticleId>
            <ArticleId IdType="pubmed">24212651</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Panier S., Boulton S.J. Double-strand break repair: 53BP1 comes into focus. Nat. Rev. 2014;15:9. doi: 10.1038/nrm3719.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrm3719</ArticleId>
            <ArticleId IdType="pubmed">24326623</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pardi N., Hogan M.J., Porter F.W., Weissman D. mRNA vaccines - a new era in vaccinology. Nat. Rev. Drug Discov. 2018;17(4):261–279. doi: 10.1038/nrd.2017.243.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrd.2017.243</ArticleId>
            <ArticleId IdType="pmc">PMC5906799</ArticleId>
            <ArticleId IdType="pubmed">29326426</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park J.W., Lagniton P., Liu Y., Xu R.H. mRNA vaccines for COVID-19: what, why and how. Int. J. Biol. Sci. 2021;17(6):1446–1460. doi: 10.7150/ijbs.59233. 2021.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7150/ijbs.59233</ArticleId>
            <ArticleId IdType="pmc">PMC8071766</ArticleId>
            <ArticleId IdType="pubmed">33907508</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Passariello M., Vetrei C., Amato F., De Lorenzo C. Interactions of spike-RBD of SARS-CoV-2 and platelet factor 4: new insights in the etiopathogenesis of thrombosis. Int. J. Mol. Sci. 2021;22:8562. doi: 10.3390/ijms22168562.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms22168562</ArticleId>
            <ArticleId IdType="pmc">PMC8395316</ArticleId>
            <ArticleId IdType="pubmed">34445266</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Passegu E., Ernst P.A. IFN-alpha wakes up sleeping hematopoietic stem cells. Nat. Med. 2009;15(6) doi: 10.1038/nm0609-612.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm0609-612</ArticleId>
            <ArticleId IdType="pmc">PMC2892628</ArticleId>
            <ArticleId IdType="pubmed">19498372</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perricone C., Ceccarelli F., Nesher G., Borella E., Odeh Q., Conti F., Shoenfeld Y., Valesini G. Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases. Immunol. Res. 2014;60:226–235. doi: 10.1007/s12026-014-8597-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12026-014-8597-x</ArticleId>
            <ArticleId IdType="pubmed">25427992</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Psichogiou M., Karabinis A., Poulakou G., Antoniadou A., Kotanidou A., Degiannis D., Pavlopoulou I.D., Chaidaroglou A., Roussos S., Mastrogianni E., et al.  Comparative immunogenicity of BNT162b2 mRNA vaccine with natural COVID-19 infection. Vaccines (Basel) 2021;9(9):1017. doi: 10.3390/vaccines9091017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/vaccines9091017</ArticleId>
            <ArticleId IdType="pmc">PMC8471735</ArticleId>
            <ArticleId IdType="pubmed">34579254</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Psichogiou M., Samarkos M., Mikos N., Hatzakis A. Reactivation of Varicella zoster virus after vaccination for SARS-CoV-2. Vaccines. 2021;9:572. doi: 10.3390/vaccines9060572.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/vaccines9060572</ArticleId>
            <ArticleId IdType="pmc">PMC8228758</ArticleId>
            <ArticleId IdType="pubmed">34205861</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qiu X.-K., Ma J. Alteration in microRNA-155 level correspond to severity of coronary heart disease. Scand. J. Clin. Lab. Invest. 2018;78(3):219–223. doi: 10.1080/00365513.2018.1435904.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/00365513.2018.1435904</ArticleId>
            <ArticleId IdType="pubmed">29411649</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qiu S., Palavicini J.P., Wang J., Gonzalez N.S., He S., Dustin E., Zou C., Ding L., Bhattacharjee A., Van Skike C.E., et al.  Adult-onset CNS myelin sulfatide deficiency is sufficient to cause Alzheimer's disease-like neuroinflammation and cognitive impairment. Mol. Neurodegener. 2021;16:64. doi: 10.1186/s13024-021-00488-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13024-021-00488-7</ArticleId>
            <ArticleId IdType="pmc">PMC8442347</ArticleId>
            <ArticleId IdType="pubmed">34526055</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Röltgen K., Nielsen S.C.A., Silva O., Younes S.F., Zaslavsky M., Costales C., Yang F., Wirz O.F., Solis D., Hoh R.A. Immune imprinting, breadth of variant recognition and germinal center response in human SARS-CoV-2 infection and vaccination. Cell. 2022 doi: 10.1016/j.cell.2022.01.018. Jan 25; S0092-8674(22)00076-9. [Epub ahead of print]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2022.01.018</ArticleId>
            <ArticleId IdType="pmc">PMC8786601</ArticleId>
            <ArticleId IdType="pubmed">35148837</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rasmussen S.A., Abul-Husn N.S., Casanova J.L., Daly M.J., Rehm H.L., Murray M.F. The intersection of genetics and COVID-19 in 2021: preview of the 2021 Rodney Howell Symposium. Genet. Med. 2021;23(6):1001–1003. doi: 10.1038/s41436-021-01113-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41436-021-01113-0</ArticleId>
            <ArticleId IdType="pmc">PMC7953182</ArticleId>
            <ArticleId IdType="pubmed">33712732</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ratajczak M.Z., Ratajczak J. Horizontal transfer of RNA and proteins between cells by extracellular microvesicles: 14 years later. Clin. Transl. Med. 2016;5:7. doi: 10.1186/s40169-016-0087-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s40169-016-0087-4</ArticleId>
            <ArticleId IdType="pmc">PMC4779088</ArticleId>
            <ArticleId IdType="pubmed">26943717</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rhea E.M., Logsdon A.F., Hanse K.M., Williams L.M., Reed M.J., Baumann K.K., Holden S.J., Raber J., Banks W.A., Erickson M.A. The S1 protein of SARS-CoV-2 crosses the blood-brain barrier in mice. Nat. Neurosci. 2021;24:368–378. doi: 10.1038/s41593-020-00771-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41593-020-00771-8</ArticleId>
            <ArticleId IdType="pmc">PMC8793077</ArticleId>
            <ArticleId IdType="pubmed">33328624</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rodrigues Figueiredo R., Aparecida Azevedo A., De Oliveira Penido N. Positive association between tinnitus and arterial hypertension. Front. Neurol. 2016;7:171. doi: 10.3389/fneur.2016.00171.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fneur.2016.00171</ArticleId>
            <ArticleId IdType="pmc">PMC5050200</ArticleId>
            <ArticleId IdType="pubmed">27761128</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rodriguez-Perez A.I., Borrajo A., Rodriguez-Pallares J., Guerra M.J., Labandeira-Garcia J.L. Interaction between NADPH-oxidase and Rho-kinase in angiotensin II-induced microglial activation. Glia. 2015;63:466e482. doi: 10.1002/glia.22765.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/glia.22765</ArticleId>
            <ArticleId IdType="pubmed">25377425</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rose J. Critical appraisal of VAERS pharmacovigilance: is the U.S. vaccine adverse events reporting system (VAERS) a Functioning pharmacovigilance system? Sci. Publ. Health Pol. the Law. 2021;3:100–129.</Citation>
        </Reference>
        <Reference>
          <Citation>Rouleau S., Glouzon J.S., Brumwell A., Bisaillon M., Perreault J.P. 3' UTR G-quadruplexes regulate miRNA binding. RNA. 2017;23(8):1172–1179. doi: 10.1261/rna.060962.117.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1261/rna.060962.117</ArticleId>
            <ArticleId IdType="pmc">PMC5513062</ArticleId>
            <ArticleId IdType="pubmed">28473452</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rouleau S.G., Garant J.-M., Balduc F., Bisaillon M., Perreault J.-P. G-Quadruplexes influence pri-microRNA processing. RNA Biol. 2018;15(2):198–206. doi: 10.1080/15476286.2017.1405211.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/15476286.2017.1405211</ArticleId>
            <ArticleId IdType="pmc">PMC5798953</ArticleId>
            <ArticleId IdType="pubmed">29171334</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rusk N. When microRNAs activate translation. Nat. Methods. 2008;5:122–123. doi: 10.1038/nmeth0208-122a.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nmeth0208-122a</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ruther U., Nunnensiek C., Muller H.A., Bader H., May U., Jipp P. Interferon alpha (IFN alpha 2a) therapy for herpes virus-associated inflammatory bowel disease (ulcerative colitis and Crohn's disease) Hepato-Gastroenterology. 1998;45(21):691–699. doi: 10.1111/j.1348-0421.1999.tb03365.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1348-0421.1999.tb03365.x</ArticleId>
            <ArticleId IdType="pubmed">9684118</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sakai Y., Ohga S., Tonegawa Y., Takada H., Nakao F., Nakayama H., Aoki T., Yamamori S., Hara T. Interferon-alpha therapy for chronic active Epstein-Barr virus infection: potential effect on the development of T- lymphoproliferative disease. J. Pediatr. Hematol. Oncol. 1998;20(4):342–346.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9703010</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sayers T.J. Targeting the extrinsic apoptosis signaling pathway for cancer therapy. Cancer Immunol. Immunother. 2011;60(8):1173–1180. doi: 10.1007/s00262-011-1008-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00262-011-1008-4</ArticleId>
            <ArticleId IdType="pubmed">21626033</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schmidt N., Lareau C.A., Keshishian H., Ganskih S., Schneider C., Hennig T., Melanson R., Werner S., Wei Y., Zimmer M., et al.  The SARS-CoV-2 RNA-protein interactome in infected human cells. Nat. Microbiol. 2021;6(3):339–353. doi: 10.1038/s41564-020-00846-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41564-020-00846-z</ArticleId>
            <ArticleId IdType="pmc">PMC7906908</ArticleId>
            <ArticleId IdType="pubmed">33349665</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schneider W.M., Chevillotte M.D., Rice C.M. Interferon-stimulated genes: a complex web of host defenses. Anni. Rev. Immunol. 2014;32:513–545.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4313732</ArticleId>
            <ArticleId IdType="pubmed">24555472</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sekiguchi K., Watanabe N., Miyazaki N., Ishizuchi K., Iba C., Tagashira Y., Uno S., Shibata M., Hasegawa N., Takemura R., et al.  Incidence of headache after COVID-19 vaccination in patients with history of headache: a cross-sectional study. Cephalalgia. 2021 doi: 10.1177/03331024211038654. [Epub ahead of print.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/03331024211038654</ArticleId>
            <ArticleId IdType="pmc">PMC8988452</ArticleId>
            <ArticleId IdType="pubmed">34407651</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seneff S., Nigh G. Worse than the disease? Reviewing some possible unintended consequences of the mRNA vaccines against COVID-19. IJVTPR. 2021;2(1):38–79.</Citation>
        </Reference>
        <Reference>
          <Citation>Shabalina S.A., Spiridonov N.A., Kashina A. Sounds of silence: synonymous nucleotides as a key to biological regulation and complexity. Nucleic Acids Res. 2013;41(4):2073–2094. doi: 10.1093/nar/gks1205.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/nar/gks1205</ArticleId>
            <ArticleId IdType="pmc">PMC3575835</ArticleId>
            <ArticleId IdType="pubmed">23293005</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shatsky I.N., Terenin I.M., Smirnova V.V., Andreev D.E. Cap-independent translation: what's in a name? Trends Biochem. Sci. 2018;43(11):882–895. doi: 10.1016/j.tibs.2018.04.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tibs.2018.04.011</ArticleId>
            <ArticleId IdType="pubmed">29789219</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shaw G., Morse S., Ararat M., Graham F.L. Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. Faseb. J. 2002;16(8):869–871. doi: 10.1096/fj.01-0995fje.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1096/fj.01-0995fje</ArticleId>
            <ArticleId IdType="pubmed">11967234</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shitrit P., Zuckerman N.S., Mor O., Gottesman B.-S., Chowers M. Nosocomial outbreak caused by the SARS-CoV-2 Delta variant in a highly vaccinated population, Israel, July 2021. Euro Surveill. 2021;26(39) doi: 10.2807/1560-7917.ES.2021.26.39.2100822.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2807/1560-7917.ES.2021.26.39.2100822</ArticleId>
            <ArticleId IdType="pmc">PMC8485578</ArticleId>
            <ArticleId IdType="pubmed">34596015</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shrotri M., Navaratnam A.M., Nguyen V., Byrne T., Geismar C., Fragaszy E., Beale S., Fong W.L.E., Patel P., Kovar J., et al.  Spike-antibody waning after second dose of BNT162b2 or ChAdOx1. Lancet. 2021;398(10298):385–387.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8285117</ArticleId>
            <ArticleId IdType="pubmed">34274038</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Simone A., Herald J., Chen A. Acute myocarditis following COVID-19 mRNA vaccination in adults aged 18 years or older. JAMA Intern. Med. 2021;181(12):1668–1670. doi: 10.1001/jamainternmed.2021.5511.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamainternmed.2021.5511</ArticleId>
            <ArticleId IdType="pmc">PMC8491129</ArticleId>
            <ArticleId IdType="pubmed">34605853</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Small E.M., Olson E.N. Pervasive roles of microRNAs in cardiovascular biology. Nature. 2011;469(7330):336–342. doi: 10.1038/nature09783.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature09783</ArticleId>
            <ArticleId IdType="pmc">PMC3073349</ArticleId>
            <ArticleId IdType="pubmed">21248840</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sola I., Almazán F., Zúñiga S., Enjuanes L. Continuous and discontinuous RNA synthesis in coronaviruses. Ann. Rev. Virol. 2015;2(1):265–288. doi: 10.1146/annurev-virology-100114-055218.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev-virology-100114-055218</ArticleId>
            <ArticleId IdType="pmc">PMC6025776</ArticleId>
            <ArticleId IdType="pubmed">26958916</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Solis M., Goubau D., Romieu-Mourez R., Genin P., Civas A., Hiscott J. Distinct functions of IRF-3 and IRF-7 in IFN-alpha gene regulation and control of anti-tumor activity in primary macrophages. Biochem. Pharmacol. 2006;72(11):1469–1476. doi: 10.1016/j.bcp.2006.06.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bcp.2006.06.002</ArticleId>
            <ArticleId IdType="pubmed">16846591</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spiegel J., Adhikari S., Balasubramanian S. The structure and function of DNA G-quadruplexes. Trend. Chem. 2020;2(2):123–136. doi: 10.1016/j.trechm.2019.07.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.trechm.2019.07.002</ArticleId>
            <ArticleId IdType="pmc">PMC7472594</ArticleId>
            <ArticleId IdType="pubmed">32923997</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stertz S., Hale B.G. Interferon system deficiencies exacerbating severe pandemic virus infections. Trends Microbiol. 2021;29(11):973–982. doi: 10.1016/j.tim.2021.03.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tim.2021.03.001</ArticleId>
            <ArticleId IdType="pmc">PMC7980109</ArticleId>
            <ArticleId IdType="pubmed">33757684</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suberbielle E., Djukic B., Evans M., Kim D.H., Taneja P., Wang X., Finucane M., Knox J., Ho K., Devidze N., et al.  DNA repair factor BRCA1 depletion occurs in Alzheimer brains and impairs cognitive function in mice. Nat. Commun. 2015;6:8897. doi: 10.1038/ncomms9897.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncomms9897</ArticleId>
            <ArticleId IdType="pmc">PMC4674776</ArticleId>
            <ArticleId IdType="pubmed">26615780</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Subramanian, S.V.; Kumar, A. Increases in COVID-19 are unrelated to levels of vaccination across 68 countries and 2947 counties in the United States. Eur. J. Epidemiol. 2021, 1-4. doi: 10.1007/s10654-021-00808-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8481107</ArticleId>
            <ArticleId IdType="pubmed">34591202</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sundstedt A., Celander M., Hedlund G. Combining tumor-targeted superantigens with interferon-alpha results in synergistic anti-tumor effects. Int. Immunopharm. 2008;8(3):442–452. doi: 10.1016/j.intimp.2007.11.006. 2008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.intimp.2007.11.006</ArticleId>
            <ArticleId IdType="pubmed">18279798</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Svitkin U.V., Herdy B., Costa-Mattioli M., Gingras A.-C., Raught B., Sonenberg N. Eukaryotic translation initiation factor 4E availability controls the switch between cap-dependent and internal ribosomal entry site-mediated translation. Mol. Cell Biol. 2005;25(23):10556–10565. doi: 10.1128/MCB.25.23.10556-10565.2005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/MCB.25.23.10556-10565.2005</ArticleId>
            <ArticleId IdType="pmc">PMC1291233</ArticleId>
            <ArticleId IdType="pubmed">16287867</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takaoka A., Tamura T., Taniguchi T. Interferon regulatory factor family of transcription factors and regulation of oncogenesis. Cancer Sci. 2008;99(3):467–478. doi: 10.1111/j.1349-7006.2007.00720.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1349-7006.2007.00720</ArticleId>
            <ArticleId IdType="pubmed">18190617</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Testa U. TRAIL/TRAIL‐R in hematologic malignancies. J. Cell. Biochem. 2010;110(1):21–34. doi: 10.1002/jcb.22549.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jcb.22549</ArticleId>
            <ArticleId IdType="pubmed">20336667</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tetz G., Tetz V. Prion-like domains in spike protein of SARS-CoV-2 differ across its variants and enable changes in affinity to ACE2. Microorganisms. 2022;10:280. doi: 10.3390/microorganisms10020280.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/microorganisms10020280</ArticleId>
            <ArticleId IdType="pmc">PMC8878784</ArticleId>
            <ArticleId IdType="pubmed">35208734</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tian W.-L., Guo R., Wang F., Jiang Z.-X., Tang P., Huang Y.-M., Sun L. The IRF9-SIRT1-P53 axis is involved in the growth of human acute myeloid leukemia. Exp. Cell Res. 2018;365:185–193. doi: 10.1016/j.yexcr.2018.02.036.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.yexcr.2018.02.036</ArticleId>
            <ArticleId IdType="pubmed">29501566</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Timmers L.F.S.M., Peixoto J.V., Ducati R.G., Bachega J.F.R., de Mattos Pereira L., Caceres R.A., Majolo F., da Silva G.L., Anton D.B., Dellagostin O.A., Henriques J.A.P., Xavier L.L., Goettert M.I., Laufer S. SARS-CoV-2 mutations in Brazil: from genomics to putative clinicalconditions. Sci. Rep. 2021;11:11998. doi: 10.1038/s41598-021-91585-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-021-91585-6</ArticleId>
            <ArticleId IdType="pmc">PMC8184806</ArticleId>
            <ArticleId IdType="pubmed">34099808</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tronvik E., Stovner L.J., Helde G., Sand T., Bovim G. Prophylactic treatment of migraine with an angiotensin II receptor-blocker: a randomized controlled trial. JAMA. 2003;289(1):65–69. doi: 10.1001/jama.289.1.65.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jama.289.1.65</ArticleId>
            <ArticleId IdType="pubmed">12503978</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Troya J., Bastard P., Planas-Serra L., Ryan P., Ruiz M., de Carranza M., Torres J., Martnez A., Abel L., Casanova J.-L., Pujol A. Neutralizing autoantibodies to type I IFNs in &gt;10% of patients with severe COVID-19 pneumonia hospitalized in Madrid, Spain. J. Clin. Immunol. 2021;41 doi: 10.1007/s10875-021-01036-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10875-021-01036-0</ArticleId>
            <ArticleId IdType="pmc">PMC8043439</ArticleId>
            <ArticleId IdType="pubmed">33851338</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tsuno T., Mejido J., Zhao T., Morrow A., Zoon K.C. IRF9 is a key factor for eliciting the antiproliferative activity of IFN-α. J. Immunother. 2009;32(8):803. doi: 10.1097/CJI.0b013e3181ad4092.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/CJI.0b013e3181ad4092</ArticleId>
            <ArticleId IdType="pmc">PMC2796296</ArticleId>
            <ArticleId IdType="pubmed">19752753</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Uranaka T., Kashio A., Ueha R., Sato T., Bing H., Ying G., Kinoshita M., Kondo K., Yamasoba T. Expression of ACE2, TMPRSS2, and furin in mouse ear tissue, and the implications for SARS-CoV-2 infection. Laryngoscope. 2021;131(6):E2013–E2017. doi: 10.1002/lary.29324.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/lary.29324</ArticleId>
            <ArticleId IdType="pubmed">33296096</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vaers Home  VAERS. https://vaers.hhs.gov/data/dataguide.html n.d.). Retrieved December 5, 2021, from.</Citation>
        </Reference>
        <Reference>
          <Citation>van der Wijst M.G.P., Vazquez S.E., Hartoularos G.C., Bastard P., Grant T., Bueno R.&gt;, Lee D.S., Greenland J.R., Sun Y., Perez R., et al.  Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19. Sci. Transl. Med. 2021;13(612) doi: 10.1126/scitranslmed.abh2624.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/scitranslmed.abh2624</ArticleId>
            <ArticleId IdType="pmc">PMC8601717</ArticleId>
            <ArticleId IdType="pubmed">34429372</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Van Lint S., Renmans D., Broos K., Dewitte H., Lentacker I., Heirman C., Breckpot K., Thielemans K. The ReNAissanCe of mRNA-based cancer therapy. Expert Rev. Vaccines. 2015;14(2):235–251. doi: 10.1586/14760584.2015.957685.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1586/14760584.2015.957685</ArticleId>
            <ArticleId IdType="pubmed">25263094</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vanderlugt C.L., Miller S.D. Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nat. Rev. Immunol. 2002;2:85–95. doi: 10.1038/nri724.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nri724</ArticleId>
            <ArticleId IdType="pubmed">11910899</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Verma A.K., Lavine K.J., Lin C.-Y. Myocarditis after covid-19 mRNA vaccination. NEJM. 2021;385:1332–1334. doi: 10.1056/NEJMc2109975.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMc2109975</ArticleId>
            <ArticleId IdType="pmc">PMC8385564</ArticleId>
            <ArticleId IdType="pubmed">34407340</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Verweij M.C., Wellish M., Whitmer T., Malouli D., Lapel M., Jonjić S., Haas J.G., DeFilippis V.R., Mahalingam R., Früh K. Varicella viruses inhibit interferon-stimulated JAK-STAT signaling through multiple mechanisms. PLoS Pathog. 2015;11(5) doi: 10.1371/journal.ppat.1004901.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.ppat.1004901</ArticleId>
            <ArticleId IdType="pmc">PMC4431795</ArticleId>
            <ArticleId IdType="pubmed">25973608</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang X.-A., Zhang R., Jiang D., Deng W., Zhang S., Deng S., Zhong J., Wang T., Zhu L.-H., Yang L., et al.  Interferon regulatory factor 9 protects against hepatic insulin resistance and steatosis in male mice. Hepatology. 2013;58(2):603–616. doi: 10.1002/hep.26368.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.26368</ArticleId>
            <ArticleId IdType="pmc">PMC3736732</ArticleId>
            <ArticleId IdType="pubmed">23471885</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang H., Hu H., Zhang K. Overview of interferon: characteristics, signaling and anti-cancer effect. Arch. Biotechnol. Biomed. 2017;1:1–16.</Citation>
        </Reference>
        <Reference>
          <Citation>Wang C., Zhang C., Liu L., A X., Chen B., Li Y., Du J. Macrophage-derived mir-155-containing exosomes suppress fibroblast proliferation and promote fibroblast inflammation during cardiac injury. Mol. Ther. 2017;25(1):192–204. doi: 10.1016/j.ymthe.2016.09.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ymthe.2016.09.001</ArticleId>
            <ArticleId IdType="pmc">PMC5363311</ArticleId>
            <ArticleId IdType="pubmed">28129114</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang N., Zhan Y., Zhu L., Hou Z., Liu F., Song P., Qiu F., Wang X., Zou X., Wan D., et al.  Retrospective multicenter cohort study shows early interferon therapy is associated with favorable clinical responses in COVID-19 patients. Cell Host Microbe. 2020;28(3):455–464. doi: 10.1016/j.chom.2020.07.005. e2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.chom.2020.07.005</ArticleId>
            <ArticleId IdType="pmc">PMC7368656</ArticleId>
            <ArticleId IdType="pubmed">32707096</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y., Nakajima T., Gonzalez F.J., Tanaka N. PPARs as metabolic regulators in the liver: lessons from liver-specific PPAR-null mice. Int. J. Mol. Sci. 2020;21:2061. doi: 10.3390/ijms21062061.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms21062061</ArticleId>
            <ArticleId IdType="pmc">PMC7139552</ArticleId>
            <ArticleId IdType="pubmed">32192216</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang E., Thombre R., Shah Y., Latanich R., Wang J. G-Quadruplexes as pathogenic drivers in neurodegenerative disorders. Nucleic Acids Res. 2021;49(9):4816–4830. doi: 10.1093/nar/gkab164.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/nar/gkab164</ArticleId>
            <ArticleId IdType="pmc">PMC8136783</ArticleId>
            <ArticleId IdType="pubmed">33784396</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wei H., Chen Q., Lin L., Sha C., Li T., Liu Y., Yin X., Xu Y., Chen L., Gao W., Li Y., Zhu X. Regulation of exosome production and cargo sorting. Int. J. Biol. Sci. 2021;17(1):163–177. doi: 10.7150/ijbs.53671.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7150/ijbs.53671</ArticleId>
            <ArticleId IdType="pmc">PMC7757038</ArticleId>
            <ArticleId IdType="pubmed">33390841</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weikert U., Kühl U., Schultheiss H.-P., Rauch U. Platelet activation is increased in patients with cardiomyopathy: myocardial inflammation and platelet reactivity. Platelets. 2002;13(8):487–491. doi: 10.1080/0953710021000057857.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/0953710021000057857</ArticleId>
            <ArticleId IdType="pubmed">12487782</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weiner J., Lewis D., Maertzdorf J., Mollenkopf H., Bodinham C., Pizzoferro K., Linley C., Greenwood A., Mantovani A., Bottazzi B., Denoel P., Leroux-Roels G., Kester K., Jónsdóttir I., van den Berg R.A., Kaufmann S., Del Giudice G. Characterization of potential biomarkers of reactogenicity of licensed antiviral vaccines: randomized controlled clinical trials conducted by the BIOVACSAFE consortium. Sci. Rep. 2019;9(1):20362. doi: 10.1038/s41598-019-56994-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-019-56994-8</ArticleId>
            <ArticleId IdType="pmc">PMC6937244</ArticleId>
            <ArticleId IdType="pubmed">31889148</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weldon C., Dacanay J.G., Gokhale V., Boddupally P.V.L., Behm-Ansmant I., Burley G.A., Branlant C., Hurley L.M., Dominguez C., Eperon I.C. Specific G-quadruplex ligands modulate the alternative splicing of Bcl-X. Nucleic Acids Res. 2018;46(2):886–896. doi: 10.1093/nar/gkx1122.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/nar/gkx1122</ArticleId>
            <ArticleId IdType="pmc">PMC5778605</ArticleId>
            <ArticleId IdType="pubmed">29156002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Williams G.D., Gokhale N.S., Snider D.L., Horner S.M. The mRNA cap 2'-O-methyltransferase CMTR1 regulates the expression of certain interferon-stimulated genes. mSphere. 2020;5(3) doi: 10.1128/mSphere.00202-20. e00202-e00220.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mSphere.00202-20</ArticleId>
            <ArticleId IdType="pmc">PMC7227766</ArticleId>
            <ArticleId IdType="pubmed">32404510</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wisnewski A.V., Campillo Luna J., Redlich C.A. Human IgG and IgA responses to COVID-19 mRNA vaccines. PLoS One. 2021;16(6) doi: 10.1371/journal.pone.0249499.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0249499</ArticleId>
            <ArticleId IdType="pmc">PMC8208542</ArticleId>
            <ArticleId IdType="pubmed">34133415</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wrapp D., Wang N., Corbett K.S., Goldsmith J.A., Hsieh C.L., Abiona O., Graham B.S., McLellan J.S. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367(6483):1260–1263. doi: 10.1126/science.abb2507.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.abb2507</ArticleId>
            <ArticleId IdType="pmc">PMC7164637</ArticleId>
            <ArticleId IdType="pubmed">32075877</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xia X. Detailed dissection and critical evaluation of the Pfizer/BioNTech and Moderna mRNA vaccines. Vaccines. 2021;9:734. doi: 10.3390/vaccines9070734.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/vaccines9070734</ArticleId>
            <ArticleId IdType="pmc">PMC8310186</ArticleId>
            <ArticleId IdType="pubmed">34358150</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yahi N., Chahinian H., Fantini J. Infection-enhancing anti-SARS-CoV-2 antibodies recognize both the original Wuhan/D614G strain and Delta variants. A potential risk for mass vaccination? J. Infect. 2021;83(5):607–635. doi: 10.1016/j.jinf.2021.08.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jinf.2021.08.010</ArticleId>
            <ArticleId IdType="pmc">PMC8351274</ArticleId>
            <ArticleId IdType="pubmed">34384810</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang C., Hu Y., Zhou B., Bao Y., Li Z., Gong C., Yang H., Wang S., Xiao Y. The role of m6A modification in physiology and disease. Cell Death Dis. 2020;11:960. doi: 10.1038/s41419-020-03143-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41419-020-03143-z</ArticleId>
            <ArticleId IdType="pmc">PMC7649148</ArticleId>
            <ArticleId IdType="pubmed">33162550</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yoshikawa F.S., Teixeira F.M., Sato M.N., Oliveira L.M. Delivery of microRNAs by extracellular vesicles in viral infections: could the news be packaged? Cells. 2019;8(6):611. doi: 10.3390/cells8060611.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/cells8060611</ArticleId>
            <ArticleId IdType="pmc">PMC6627707</ArticleId>
            <ArticleId IdType="pubmed">31216738</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu X., Odenthal M., Fries J.W.U. Exosomes as miRNA carriers: formation–function–future. Int. J. Mol. Sci. 2016;17:2028. doi: 10.3390/ijms17122028.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms17122028</ArticleId>
            <ArticleId IdType="pmc">PMC5187828</ArticleId>
            <ArticleId IdType="pubmed">27918449</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zaccara S., Ries R.J., Jaffrey S.R. Reading, writing and erasing mRNA methylation. Nat. Rev. 2019;20:608–624. doi: 10.1038/s41580-019-0168-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41580-019-0168-5</ArticleId>
            <ArticleId IdType="pubmed">31520073</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zakaria Z., Sapiai N.A., Izaini Ghani A.R. Cerebral venous sinus thrombosis 2 weeks after the first dose of mRNA SARS‐CoV‐2 vaccine. Acta Neurochir. 2021;163(8):2359–2362. doi: 10.1007/s00701-021-04860-w.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00701-021-04860-w</ArticleId>
            <ArticleId IdType="pmc">PMC8186353</ArticleId>
            <ArticleId IdType="pubmed">34101024</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang J., Powell S.N. The role of the BRCA1 tumor suppressor in DNA double-strand break repair. Mol. Cancer Res. 2005;3(10):531–539. doi: 10.1158/1541-7786.MCR-05-0192.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/1541-7786.MCR-05-0192</ArticleId>
            <ArticleId IdType="pubmed">16254187</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang W., Luo J., Yang F., Wang Y., Yin Y., Strom A., Gustafsson J.Å., Guan X. BRCA1 inhibits AR-mediated proliferation of breast cancer cells through the activation of SIRT1. Sci. Rep. 2016;6:22034. doi: 10.1038/srep22034.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/srep22034</ArticleId>
            <ArticleId IdType="pmc">PMC4763204</ArticleId>
            <ArticleId IdType="pubmed">26902145</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang R., Xiao K., Gu Y., Liu H., Sun X. Whole genome identification of potential G-quadruplexes and analysis of the G-quadruplex binding domain for SARS-CoV-2. Front. Genet. 2020;11 doi: 10.3389/fgene.2020.587829.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fgene.2020.587829</ArticleId>
            <ArticleId IdType="pmc">PMC7728997</ArticleId>
            <ArticleId IdType="pubmed">33329730</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao Y., Chen W., Zhu W., Meng H., Chen J., Zhang J. Overexpression of interferon regulatory factor 7 (IRF7) reduces bone metastasis of prostate cancer cells in mice. Oncol. Res. 2017;25(4):511. doi: 10.3727/096504016X14756226781802.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3727/096504016X14756226781802</ArticleId>
            <ArticleId IdType="pmc">PMC7841009</ArticleId>
            <ArticleId IdType="pubmed">27733217</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou M., Guo J., Cha J., Chae M., Chen S., Barral J.M., Sachs M.S., Liu Y. Non-optimal codon usage affects expression, structure and function of clock protein FRQ. Nature. 2013;495(7439):111–115. doi: 10.1038/nature11833.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature11833</ArticleId>
            <ArticleId IdType="pmc">PMC3629845</ArticleId>
            <ArticleId IdType="pubmed">23417067</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zin Tun G.S., Gleeson D., Al-Joudeh A., Dube A. Immune-mediated hepatitis with the Moderna vaccine, no longer a coincidence but confirmed. J. Hepatol. 2021 doi: 10.1016/j.jhep.2021.09.031. Oct 5. [Epub ahead of print]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jhep.2021.09.031</ArticleId>
            <ArticleId IdType="pmc">PMC8491984</ArticleId>
            <ArticleId IdType="pubmed">34619252</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zitvogel L., Galluzzi L., Kepp O., Smyth M.J., Kroemer G. Type I interferons in anticancer immunity. Nat. Rev. Immunol. 2015;15(7):405–414. doi: 10.1038/nri3845.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nri3845</ArticleId>
            <ArticleId IdType="pubmed">26027717</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zoll J., Erkens Hulshof S., Lanke K., Verduyn Lunel F., Melchers W.J., Schoondermark-van de Ven E., Roivainen M., Galama J.M., van Kuppeveld F.J. Saffold virus, a human Theiler's-like cardiovirus, is ubiquitous and causes infection early in life. PLoS Pathog. 2009;5(5) doi: 10.1371/journal.ppat.1000416.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.ppat.1000416</ArticleId>
            <ArticleId IdType="pmc">PMC2670511</ArticleId>
            <ArticleId IdType="pubmed">19412527</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
